Back to ROIV
VIKING GLOBAL INVESTORS LP → ROIV
VIKING GLOBAL INVESTORS LP ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
14
Latest value
$221.9M
Q2 2026
Peak value
$857.7M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $651.2M |
| Q2 2023 | $758.4M |
| Q3 2023 | $857.7M |
| Q4 2023 | $779M |
| Q1 2024 | $731.1M |
| Q2 2024 | $731M |
| Q3 2024 | $624.3M |
| Q4 2024 | $565.6M |
| Q1 2025 | $464.3M |
| Q2 2025 | $385.9M |
| Q3 2025 | $357M |
| Q4 2025 | $139.8M |
| Q1 2026 | $184.3M |
| Q2 2026 | $221.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $221.9M | 6.27M | — | — |
| Q1 2026 | $184.3M | 6.65M | — | — |
| Q4 2025 | $139.8M | 6.44M | — | — |
| Q3 2025 | $357M | 23.59M | — | — |
| Q2 2025 | $385.9M | 34.24M | — | — |
| Q1 2025 | $464.3M | 46.01M | — | — |
| Q4 2024 | $565.6M | 47.81M | — | — |
| Q3 2024 | $624.3M | 54.10M | — | — |
| Q2 2024 | $731M | 69.16M | — | — |
| Q1 2024 | $731.1M | 69.37M | — | — |
| Q4 2023 | $779M | 69.37M | — | — |
| Q3 2023 | $857.7M | 73.43M | — | — |
| Q2 2023 | $758.4M | 75.24M | — | — |
| Q1 2023 | $651.2M | 88.24M | — | — |
Other funds holding ROIV
$1.2B
$1.2B
$841.4M
$629.8M
$629.8M
$560.3M